July 10, 2025 · Form 4 insider transaction
Krogulski Kenneth bought 80 shares of Cumberland Pharmaceuticals Inc. at $3.20 per share, a transaction worth $256.00. The trade was recorded as open-market purchase under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 32 days after the transaction.
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.